Evercore ISI Group Maintains In-Line on Bio-Techne, Lowers Price Target to $54
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Evercore ISI Group analyst Daniel Markowitz maintains Bio-Techne (NASDAQ:TECH) with a In-Line and lowers the price target from $68 to $54.
Evercore ISI Group analyst Daniel Markowitz maintains Bio-Techne (NASDAQ:TECH) with a In-Line and lowers the price target from $68 to $54.